With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

Illumina (ILMN) has been grinding higher over the past month, even though the stock is still down over the past year, raising a simple question for investors: is this quiet rebound worth leaning into?

Illumina's stock has seen a modest increase in its Fair Value Estimate, rising from $113.58 to $117.74. This reflects improved analyst confidence in the company's future prospects. This change comes ...

Illumina (ILMN) shares have shown steady movement recently, catching the attention of investors looking at biotech trends. With its latest quarterly performance, investors are considering how ongoing ...